International Stem Cell Corporation (ISCO)
OTCMKTS
· Delayed Price · Currency is USD
0.1667
+0.0125 (8.11%)
May 28, 2025, 3:17 PM EDT
International Stem Cell Employees
International Stem Cell had 32 employees as of December 31, 2024. The number of employees increased by 3 or 10.34% compared to the previous year.
Employees
32
Change (1Y)
3
Growth (1Y)
10.34%
Revenue / Employee
$283,906
Profits / Employee
-$7,844
Market Cap
1.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
American Oncology Network | 1,914 |
International Stem Cell News
- 2 months ago - International Stem Cell GAAP EPS of -$0.03, revenue of $9.09M - Seeking Alpha
- 2 months ago - International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results - Accesswire
- 1 year ago - Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting. - Business Wire
- 3 years ago - International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022 - Accesswire